Renalytix Plc
RNLXY
$1.24
-$0.13-9.19%
OTC PK
| 12/31/2025 | 09/30/2025 | 12/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 2.42M | 2.22M | 2.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 2.42M | 2.22M | 2.41M |
| Cost of Revenue | -- | -- | 1.95M | 2.26M | 2.26M |
| Gross Profit | -- | -- | 470.00K | -35.00K | 152.00K |
| SG&A Expenses | -- | -- | 15.90M | 21.70M | 24.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 21.38M | 35.52M | 40.49M |
| Operating Income | -- | -- | -18.96M | -33.29M | -38.08M |
| Income Before Tax | -- | -- | -23.42M | -37.48M | -41.84M |
| Income Tax Expenses | -- | -- | 0.00 | 8.00K | 7.00K |
| Earnings from Continuing Operations | -- | -- | -23.42 | -37.49 | -41.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -23.42M | -37.49M | -41.85M |
| EBIT | -- | -- | -18.96M | -33.29M | -38.08M |
| EBITDA | -- | -- | -18.71M | -32.97M | -37.69M |
| EPS Basic | -- | -- | -0.19 | -0.39 | -0.45 |
| Normalized Basic EPS | -- | -- | -0.10 | -0.21 | -0.26 |
| EPS Diluted | -- | -- | -0.19 | -0.40 | -0.46 |
| Normalized Diluted EPS | -- | -- | -0.10 | -0.21 | -0.26 |
| Average Basic Shares Outstanding | -- | -- | 554.87M | 383.43M | 371.34M |
| Average Diluted Shares Outstanding | -- | -- | 554.87M | 383.43M | 371.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |